Specifically, module I is highly activated in the six DCIS areas identified in the original study, representing the spatial expression of breast cancer markers such as SPINT2, FXYD3, and ERBB2 [35]. The gene discussed is FXYD3; the disease is ductal breast carcinoma in situ.